Joshua McDonald Forex.

Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology von Lilienfeld-Toal M, Berger A, Christopeit M, Hentrich M, Heussel C, Kalkreuth J, Klein M, Kochanek M, Penack O, Hauf E, Rieger C, Silling G, Vehreschild M, Weber T, Wolf H, Lehners N, Schalk E, Mayer K EUR J CANCER. Potentially Inappropriate Medication Use in Multimorbid Elderly Inpatients: Differences Between the FORTA, PRISCUS and STOPP Ratings Wickop B, Härterich S, Sommer C, Daubmann A, Baehr M, Langebrake C Drugs Real World Outcomes.

Plato. Vertikale Suche. Ai.

Übersicht - Gentherapeutische Konzepte in der Onkologie Abramowski P, Fehse B TumorDiagn Ther. Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma Auner H, Garderet L, Kröger N BRIT J HAEMATOL. Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria Ayuketang F, Veit R, Zabelina T, Bussmann L, Christopeit M, Alchalby H, Wolschke C, Lellek H, Bacher U, Zander A, Kröger N ANN HEMATOL.

Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT Trial Bader P, Kreyenberg H, von Stackelberg A, Eckert C, Salzmann-Manrique E, Meisel R, Poetschger U, Stachel D, Schrappe M, Alten J, Schrauder A, Schulz A, Lang P, Müller I, Albert M, Willasch A, Klingebiel T, Peters C J CLIN ONCOL.

Publikationen

How we manage JAK inhibition in allogeneic transplantation for myelofibrosis Ballinger T, Savani B, Gupta V, Kröger N, Mohty M EUR J HAEMATOL. SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation Bartels S, Lehmann U, Büsche G, Schlue J, Mozer M, Stadler J, Triviai I, Alchalby H, Kröger N, Kreipe H LEUKEMIA. Magnetic resonance enterography for assessment of intestinal graft-versus-host disease after allogeneic stem cell transplantation Derlin T, Laqmani A, Veldhoen S, Apostolova I, Ayuketang F, Adam G, Kröger N, Bannas P EUR RADIOL.

Gentherapie - zurück in die Zukunft? Fehse B BIOspektrum. Genetische Manipulation: klinische Anwendung. Fehse B, Cornils K Hämatopoetische Stammzellen. Herr W, Theobald M, Ehninger G, Einsele H, Meyer R Hrsg. Köln: Deutscher Ärzte-Verlag, Themenbereich somatische Gentherapie: Translationale und klinische Forschung Fehse B, Domasch S Dritter Gentechnologiebericht: Analyse einer Hochtechnologie.

Müller-Röber B, Budisa N, Diekämper J, Domasch S, Fehse B, Hampel J, Hucho F, Hümpel A, Köchy K, Marx-Stölting L, Reich J, Rheinberger H, Ropers H, Taupitz J, Walter J, Zenke M Hrsg.

Search Traders University | Interactive Brokers Luxembourg SARL

Baden Baden: Nomos, Evaluation of Unbiased Next-Generation Sequencing of RNA RNA-seq as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples Fischer N, Indenbirken D, Meyer T, Lütgehetmann M, Lellek H, Spohn M, Aepfelbacher M, Alawi M, Grundhoff A J CLIN MICROBIOL. Multicolor RGB Marking Allows Morphometric and Functional Analysis of Hippocampal Granule Neurons at the Single-Cell Level Gomez-Nicola D, Riecken K, Perry V, Fehse B HUM GENE THER.

Joshua Martinez's This Weeks Idea: EUR/ AUD Reversal 600 PIP Opportunity

Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study Gratwohl A, Sureda A, Baldomero H, Gratwohl M, Dreger P, Kröger N, Ljungman P, McGrath E, Mohty M, Nagler A, Rambaldi A, de Elvira C, Snowden J, Passweg J, Apperley J, Niederwieser D, Stijnen T, Brand R EBioMedicine. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis Heim D, Cornils K, Schulze K, Fehse B, Lohse A, Brümmendorf T, Wege H ONCOGENE.

Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q Heuser M, Meggendorfer M, Cruz M, Fabisch J, Klesse S, Köhler L, Göhring G, Ganster C, Shirneshan K, Gutermuth A, Cerny-Reiterer S, Krönke J, Panagiota V, Haferlach C, Koenecke C, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Ehrlich S, Stamer K, Döhner K, Valent P, Schlegelberger B, Kroeger N, Ganser A, Haase D, Haferlach T, Thol F LEUKEMIA. Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM prospective trial Iacobelli S, de Wreede L, Schönland S, Björkstrand B, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Carella A, Beksac M, Bosi A, Milone G, Corradini P, Friberg K, van Biezen A, Goldschmidt H, de Witte T, Morris C, Niederwieser D, Garderet L, Kröger N, Gahrton G BONE MARROW TRANSPL.

Activation of Cell Surface Bound 20S Proteasome Inhibits Vascular Cell Growth and Arteriogenesis Ito W, Lund N, Zhang Z, Buck F, Lellek H, Horst A, Machens H, Schunkert H, Schaper W, Meinertz T BIOMED RES INT. Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Kharfan-Dabaja M, Labopin M, Bazarbachi A, Socie G, Kroeger N, Blaise D, Veelken H, Bermudez A, Or R, Lioure B, Beelen D, Fegueux N, Hamladji R, Nagler A, Mohty M LEUKEMIA RES.

Risk of Rotavirus Vaccination for Children with SCID Klinkenberg D, Blohm M, Hoehne M, Mas Marques A, Malecki M, Schildgen V, Schneppenheim R, Müller I, Schildgen O, Kobbe R PEDIATR INFECT DIS J. Stammzelltransplantation bei malignen Lymphomen Hat sie noch eine Bedeutung? Klyuchnikov E, Bacher U ONKOLOGE. Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kröger N, Hari P, Ku G, Ayala E, Chen A, Chen Y, Cohen J, Freytes C, Gale R, Kamble R, Kharfan-Dabaja M, Lazarus H, Martino R, Mussetti A, Savani B, Schouten H, Usmani S, Wiernik P, Wirk B, Smith S, Sureda A, Hamadani M BONE MARROW TRANSPL.

Extracellular Vesicles from MSC Modulate the Immune Response to Renal Allografts in a MHC Disparate Rat Model Koch M, Lemke A, Lange C Stem Cells Int. Current Challenges in Stem Cell Transplantation in Myelofibrosis Kröger N Curr Hematol Malig Rep. Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group GMALL Kröger N, Bornhäuser M, Stelljes M, Pichlmeier U, Trenschel R, Schmid C, Arnold R, Martin H, Heinzelmann M, Wolschke C, Meyer R, Bethge W, Kobbe G, Ayuketang F, Gökbuget N, Hölzer D, Zander A, Beelen D BONE MARROW TRANSPL.

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years with primary myelofibrosis Kröger N, Giorgino T, Scott B, Ditschkowski M, Alchalby H, Cervantes F, Vannucchi A, Cazzola M, Morra E, Zabelina T, Maffioli M, Pereira A, Beelen D, Deeg H, Passamonti F BLOOD. Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients Kruchen A, Stahl T, Gieseke F, Binder T, Özcan Z, Meisel R, Kreyenberg H, Bader P, Gruhn B, Greil J, Pfeiffer M, Döring M, Handgretinger R, Fehse B, Müller I BONE MARROW TRANSPL.

Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I Kühn S, Koehne T, Cornils K, Markmann S, Riedel C, Pestka J, Schweizer M, Baldauf C, Yorgan T, Krause M, Keller J, Neven M, Breyer S, Stücker R, Muschol N, Busse B, Braulke T, Fehse B, Amling M, Schinke T HUM MOL GENET.

Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma Lajmi N, Luetkens T, Yousef S, Templin J, Cao Y, Hildebrandt Y, Bartels K, Kröger N, Atanackovic D BRIT J HAEMATOL. Mesenchymal Stromal Cells Protect From Acute Radiation Syndromes: Insights into Possible Mechanisms Lange C Medico-Biological and Socio-Psychological Problems of Safety in Emergency Situations. Treatment of Acute Radiation Syndromes with Transplantation of Bone Marrow-derived Mesenchymal Stromal Cells.

Lange C, Reimer R, Zustin J, Brunswig-Spickenheier B Biological Responses, Monitoring and Protection from Radiation Exposure. Mishra K Hrsg. Hauppauge, NY , USA: Nova Science Publishers, Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy Lellek H, Franke G, Ruckert C, Wolters M, Wolschke C, Christner M, Büttner H, Alawi M, Kröger N, Rohde H INT J MED MICROBIOL.

Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation. Mendorf A, Klyuchnikov E, Langebrake C, Rohde H, Ayuketang F, Regier M, Christopeit M, Zabelina T, Bacher A, Stübig T, Wolschke C, Bacher U, Kroger N ACTA HAEMATOL-BASEL.

Tipps und Chancen für Newcastle Knights gegen Canterbury Bulldogs - NRL 2021

Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen Michaelis M, Agha B, Rothweiler F, Löschmann N, Voges Y, Mittelbronn M, Starzetz T, Harter P, Abhari B, Fulda S, Westermann F, Riecken K, Spek S, Langer K, Wiese M, Dirks W, Zehner R, Cinatl J, Wass M, Cinatl J SCI REP-UK. Gezielter CCR5-Knockout in primären T-Lymphozyten zur Verhinderung der HIV-Infektion Mock U, Fehse B The Paideia Group, Efficacy and outcome of allogeneic transplantation in IgD and non secretory myeloma.

A report on behalf of the myeloma subcommittee of the Chronic Malignancies Working Party of the EBMT Morris C, Iacobelli S, Gahrton G, van Biezen A, Drake M, Garderet L, Potter M, Schattenberg A, Cornelissen J, Hamladji R, Martelli M, Petersen E, Rovira M, Bandini G, Kröger N, de Witte T BIOL BLOOD MARROW TR. Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis Nikitenko N, Speiseder T, Groitl P, Spirin P, Prokofjeva M, Lebedev T, Rubtsov P, Lam E, Riecken K, Fehse B, Dobner T, Prassolov V BIOCHIMIE.

New IDH1 mutant inhibitors for treatment of acute myeloid leukemia Okoye-Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, Rominger C, Quinn C, Smallwood A, Wiggall K, Reif A, Schmidt S, Qi H, Zhao H, Joberty G, Faelth-Savitski M, Bantscheff M, Drewes G, Duraiswami C, Brady P, Groy A, Narayanagari S, Antony-Debre I, Mitchell K, Wang H, Kao Y, Christopeit M, Carvajal L, Barreyro L, Paietta E, Makishima H, Will B, Concha N, Adams N, Schwartz B, McCabe M, Maciejewski J, Verma A, Steidl U NAT CHEM BIOL. Hematopoietic SCT in Europe recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants Passweg J, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte R, Dufour C, Falkenburg J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M BONE MARROW TRANSPL.

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease? Radujkovic A, Guglielmi C, Bergantini S, Iacobelli S, van Biezen A, Milojkovic D, Gratwohl A, Schattenberg A, Verdonck L, Niederwieser D, de Witte T, Kröger N, Olavarria E BIOL BLOOD MARROW TR.

Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation Rapp A, Bindl R, Heilmann A, Erbacher A, Müller I, Brenner R, Ignatius A EUR CELLS MATER. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT Ruutu T, de Wreede L, van Biezen A, Brand R, Mohty M, Dreger P, Duarte R, Peters C, Garderet L, Schönland S, Gratwohl A, Niederwieser D, de Witte T, Kröger N BONE MARROW TRANSPL. Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study Shouval R, Labopin M, Bondi O, Mishan-Shamay H, Shimoni A, Ciceri F, Esteve J, Giebel S, Gorin N, Schmid C, Polge E, Aljurf M, Kroger N, Craddock C, Bacigalupo A, Cornelissen J, Baron F, Unger R, Nagler A, Mohty M J CLIN ONCOL.

Digital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantation Stahl T, Böhme M, Kröger N, Fehse B EXP HEMATOL. Stammzelltransplantation bei Multipler Sklerose. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, Sureda A, Bader P, Cesaro S, Dreger P, Duarte R, Dufour C, Falkenburg J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Marsh J, Nagler A, Peters C, Velardi A, Mohty M, Madrigal A BONE MARROW TRANSPL.

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation Symeonidis A, van Biezen A, de Wreede L, Piciocchi A, Finke J, Beelen D, Bornhäuser M, Cornelissen J, Volin L, Mufti G, Chalandon Y, Ganser A, Bruno B, Niederwieser D, Kobbe G, Schwerdtfeger R, de Witte T, Robin M, Kröger N BRIT J HAEMATOL.

Erratum for "Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors" Trepel M, Körbelin J, Spies E, Heckmann M, Hunger A, Fehse B, Katus H, Kleinschmidt J, Müller O, Michelfelder S GENE THER. Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors Trepel M, Körbelin J, Spies E, Heckmann M, Hunger A, Fehse B, Katus H, Kleinschmidt J, Müller O, Michelfelder S GENE THER. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Vannucchi A, Barbui T, Cervantes F, Harrison C, Kiladjian J, Kröger N, Thiele J, Buske C ANN ONCOL.

Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma Waizenegger J, Ben-Batalla I, Weinhold N, Meissner T, Wroblewski M, Janning M, Riecken K, Binder M, Atanackovic D, Taipaleenmaeki H, Schewe D, Sawall S, Gensch V, Cubas-Cordova M, Seckinger A, Fiedler W, Hesse E, Kröger N, Fehse B, Hose D, Klein B, Raab M, Pantel K, Bokemeyer C, Loges S LEUKEMIA. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects Wellbrock J, Latuske E, Köhler J, Wagner K, Stamm H, Vettorazzi E, Vohwinkel G, Klokow M, Uibeleisen R, Ehm P, Riecken K, Loges S, Thol F, Schubert C, Amling M, Jücker M, Bokemeyer C, Heuser M, Krauter J, Fiedler W CLIN CANCER RES.

Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma Yousef S, Heise J, Lajmi N, Bartels K, Kröger N, Luetkens T, Atanackovic D J TRANSL MED. Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients Yousef S, Marvin J, Steinbach M, Langemo A, Kovacsovics T, Binder M, Kröger N, Luetkens T, Atanackovic D BLOOD CANCER J. A truncation variant of the cation channel P2RX5 is upregulated during T cell activation Abramowski P, Ogrodowczyk C, Martin R, Pongs O PLOS ONE.

The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response Abramowski P, Otto B, Martin R PLOS ONE. Allogeneic stem cell transplant vs. Janus kinase inhibition in the treatment of primary myelofibrosis or myelofibrosis after essential thrombocythemia or polycythemia vera Alchalby H, Kröger N CL LYMPH MYELOM LEUK.

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation Alchalby H, Zabelina T, Stübig T, van Biezen A, Bornhäuser M, Di Bartolomeo P, Beelen D, Cahn J, Dreger P, Schroyens W, de Witte T, Olavarria E, Kröger N BIOL BLOOD MARROW TR.

Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma Atanackovic D, Luetkens T, Kröger N LEUKEMIA.

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years Auner H, Szydlo R, Hoek J, Goldschmidt H, Stoppa A, Morgan G, Moreau P, Attal M, Marit G, Russell N, Brune M, Cook G, Sonneveld P, Schönland S, Garderet L, Kröger N BONE MARROW TRANSPL. Selected CD34 Stem cells for Graft Engineering: 34 Case Reports in Hematopoietic Stem Cell Transplantation Aversa F, Kroger N Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation Ayuketang F, Bussmann L, Zabelina T, Veit R, Alchalby H, Wolschke C, Lellek H, Bacher U, Zander A, Kröger N ANN HEMATOL.

Kopplung von elektronischer Verordnung und patientenorientierter Logistik Baehr M, van der Linde A, König R, Melzer S, Langebrake C, Grothe-Tenberge C, Hug M Krankenhauspharmazie. Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET ELN and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment IWG-MRT Barosi G, Tefferi A, Besses C, Birgegard G, Cervantes F, Finazzi G, Gisslinger H, Griesshammer M, Harrison C, Hehlmann R, Hermouet S, Kiladjian J, Kröger N, Mesa R, Mc Mullin M, Pardanani A, Passamonti F, Samuelsson J, Vannucchi A, Reiter A, Silver R, Verstovsek S, Tognoni G, Barbui T LEUKEMIA.

TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer Berdien B, Mock U, Atanackovic D, Fehse B GENE THER. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation Chemaly R, Ullmann A, Stoelben S, Richard M, Bornhäuser M, Groth C, Einsele H, Silverman M, Mullane K, Brown J, Nowak H, Kölling K, Stobernack H, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Champlin R, Ehninger G NEW ENGL J MED.

IMWG consensus on risk stratification in multiple myeloma Chng W, Dispenzieri A, Chim C, Fonseca R, Goldschmidt H, Lentzsch S, Munshi N, Palumbo A, Miguel J, Sonneveld P, Cavo M, Usmani S, Durie B, Avet-Loiseau H LEUKEMIA. Relapse assessment following allogeneic SCT in patients with MDS and AML Christopeit M, Kröger N, Haferlach T, Bacher U ANN HEMATOL. Multiplexing clonality: combining RGB marking and genetic barcoding Cornils K, Thielecke L, Hüser S, Forgber M, Thomaschewski M, Kleist N, Hussein K, Riecken K, Volz T, Gerdes S, Glauche I, Dahl A, Dandri M, Roeder I, Fehse B NUCLEIC ACIDS RES.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation de Lima M, Porter D, Battiwalla M, Bishop M, Giralt S, Hardy N, Kröger N, Wayne A, Schmid C BIOL BLOOD MARROW TR.

Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy or hypomethylating agent therapy? Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study de Wreede L, Watson M, van Os M, Milligan D, van Gelder M, Michallet M, Dreger P, Dearden C, Homewood J, Dupuis J, Leporrier M, Karas M, Corront B, Baerlocher G, Herr W, Choquet S, Niederwieser D, Sutton L, Kröger N, de Witte T, Schetelig On Behalf Of The Chronic Malignancies Working Party Of The Ebmt And The Uk Medical Research Council J AM J HEMATOL.

Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation Döring M, Blume O, Haufe S, Hartmann U, Kimmig A, Schwarze C, Lang P, Handgretinger R, Müller I EUR J CLIN MICROBIOL.


  • Wissenschaftliche Publikationen unserer Mitarbeiter.
  • UK Forex Brokers reguliert;
  • Bestes Forex-Indikatorsignal!
  • druck auf forex platten?
  • Kostenlose Optionshandel..

Neural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult mice Flachsbarth K, Kruszewski K, Jung G, Jankowiak W, Riecken K, Wagenfeld L, Richard G, Fehse B, Bartsch U INVEST OPHTH VIS SCI. In-vivo RGB marking and multicolour single-cell tracking in the adult brain Gomez-Nicola D, Riecken K, Fehse B, Perry V SCI REP-UK. Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration Gomez-Nicola D, Suzzi S, Vargas-Caballero M, Fransen N, Al-Malki H, Cebrian-Silla A, Garcia-Verdugo J, Riecken K, Fehse B, Perry V BRAIN.

Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis Gupta V, Gotlib J, Radich J, Kröger N, Rondelli D, Verstovsek S, Deeg H BIOL BLOOD MARROW TR. Selectins mediate small cell lung cancer systemic metastasis Heidemann F, Schildt A, Schmid K, Bruns O, Riecken K, Jung C, Ittrich H, Wicklein D, Reimer R, Fehse B, Heeren J, Lüers G, Schumacher U, Heine M PLOS ONE. Low frequency of calreticulin mutations in MDS patients Heuser M, Panagiota V, Koenecke C, Fehse B, Alchalby H, Badbaran A, Shahswar R, Stadler M, Eder M, Göhring G, Trummer A, Schroeder T, Kobbe G, Thiede C, Platzbecker U, Schlegelberger B, Kroeger N, Ganser A, Thol F LEUKEMIA.

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how? Klyuchnikov E, Bacher U, Kroll T, Shea T, Lazarus H, Bredeson C, Fenske T BONE MARROW TRANSPL. Gentherapie Köchy K, Domasch S, Fehse B Lenk C, Duttge G, Fangerau H Hrsg. Berlin, Heidelberg: Springer, - Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cells Kötter A, Cornils K, Borgmann K, Dahm-Daphi J, Petersen C, Dikomey E, Mansour Khalfallah W MOL ONCOL. Immune-modulating drugs and hypomethylating agents to prevent or treat relapse after allogeneic stem cell transplantation Kröger N, Stübig T, Atanackovic D BIOL BLOOD MARROW TR.

Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis Kröger N, Zabelina T, Alchalby H, Stübig T, Wolschke C, Ayuketang F, von Huenerbein N, Kvasnicka H, Thiele J, Kreipe H, Büsche G BIOL BLOOD MARROW TR. Formale Kriterien für eine gute Verordnung im stationären Bereich Langebrake C, Melzer S, Baehr M Ther Umsch. Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation Luetkens T, Kobold S, Cao Y, Ristic M, Schilling G, Tams S, Bartels B, Templin J, Bartels K, Hildebrandt Y, Yousef S, Marx A, Haag F, Bokemeyer C, Kröger N, Atanackovic D CANCER IMMUNOL IMMUN.

Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases Mock U, Riecken K, Berdien B, Qasim W, Chan E, Cathomen T, Fehse B SCI REP-UK. Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation Mohty M, Hübel K, Kröger N, Aljurf M, Apperley J, Basak G, Bazarbachi A, Douglas K, Gabriel I, Garderet L, Geraldes C, Jaksic O, Kattan M, Koristek Z, Lanza F, Lemoli R, Mendeleeva L, Mikala G, Mikhailova N, Nagler A, Schouten H, Selleslag D, Suciu S, Sureda A, Worel N, Wuchter P, Chabannon C, Duarte R BONE MARROW TRANSPL.

Should the standard dimethyl sulfoxide concentration be reduced? Allogeneic hematopoietic SCT for adults AML using i. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation Panagiota V, Thol F, Markus B, Fehse B, Alchalby H, Badbaran A, Lehmann U, Koenecke C, Shahswar R, Chaturvedi A, Stadler M, Eder M, Göhring G, Koenigsmann M, Kloos A, Trummer A, Schroeder T, Kobbe G, Thiede C, Platzbecker U, Schlegelberger B, Kreipe H, Ganser A, Kröger N, Heuser M LEUKEMIA.

Hematopoietic SCT in Europe: data and trends in with special consideration of pediatric transplantation Passweg J, Baldomero H, Peters C, Gaspar H, Cesaro S, Dreger P, Duarte R, Falkenburg J, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A BONE MARROW TRANSPL. Management of sepsis in neutropenic patients: updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology AGIHO Penack O, Becker C, Buchheidt D, Christopeit M, Kiehl M, von Lilienfeld-Toal M, Hentrich M, Reinwald M, Salwender H, Schalk E, Schmidt-Hieber M, Weber T, Ostermann H ANN HEMATOL.

Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis Robin M, Giannotti F, Deconinck E, Mohty M, Michallet M, Sanz G, Chevallier P, Cahn J, Legrand F, Rovira M, Passweg J, Sierra J, Nguyen S, Maillard N, Yakoub-Agha I, Linkesch W, Cannell P, Marcatti M, Bay J, Chalandon Y, Kröger N, Gluckman E, Rocha V, Olavarria E, Ruggeri A BIOL BLOOD MARROW TR. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT Sarkar S, Scherwath A, Schirmer L, Schulz-Kindermann F, Neumann K, Kruse M, Dinkel A, Kunze S, Balck F, Kröger N, Koch U, Mehnert A BONE MARROW TRANSPL.

Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions-A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group Schroeder T, Rachlis E, Bug G, Stelljes M, Klein S, Steckel N, Wolf D, Ringhoffer M, Czibere A, Nachtkamp K, Dienst A, Kondakci M, Stadler M, Platzbecker U, Uharek L, Luft T, Fenk R, Germing U, Bornhäuser M, Kröger N, Beelen D, Haas R, Kobbe G BIOL BLOOD MARROW TR. Cell adhesion molecules in metastatic neuroblastoma models Schwankhaus N, Gathmann C, Wicklein D, Riecken K, Schumacher U, Valentiner U CLIN EXP METASTAS.

7 Dinge, die Sie wissen sollten, bevor Sie Crypto in Australien kaufen

Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis Stern M, de Wreede L, Brand R, van Biezen A, Dreger P, Mohty M, de Witte T, Kröger N, Ruutu T LEUKEMIA. Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis Triviai I, Ziegler M, Bergholz U, Oler A, Stübig T, Prassolov V, Fehse B, Kozak C, Kröger N, Stocking C P NATL ACAD SCI USA. Gute Verordnungspraxis bei älteren Patienten Wickop B, Langebrake C Ther Umsch. Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous Transplantation: a study by the European Group for Blood and Marrow Transplantation Auner H, Szydlo R, van Biezen A, Iacobelli S, Gahrton G, Milpied N, Volin L, Janssen J, Nguyen Quoc S, Michallet M, Schoemans H, El Cheikh J, Petersen E, Guilhot F, Schönland S, Ahlberg L, Morris C, Garderet L, de Witte T, Kröger N BONE MARROW TRANSPL.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies Avigan D, Hari P, Battiwalla M, Bishop M, Giralt S, Hardy N, Kröger N, Wayne A, Hsu K BIOL BLOOD MARROW TR.

Donor choice according to age for allo-SCT for AML in complete remission Ayuketang F, Zabelina T, Wortmann F, Alchalby H, Wolschke C, Lellek H, Bacher U, Zander A, Kröger N BONE MARROW TRANSPL. Moderne Bildgebungsverfahren beim Multiplen Myelom Bannas P, Kröger N, Adam G, Derlin T ROFO-FORTSCHR RONTG. Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma Ben Batalla I, Schultze A, Wroblewski M, Erdmann R, Heuser M, Waizenegger J, Riecken K, Binder M, Schewe D, Sawall S, Witzke V, Cubas Cordova M, Janning M, Wellbrock J, Fehse B, Hagel C, Krauter J, Ganser A, Lorens J, Fiedler W, Carmeliet P, Pantel K, Bokemeyer C, Loges S BLOOD.

Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer Bhattacharyya S, Yu Y, Suzuki M, Campbell N, Mazdo J, Vasanthakumar A, Bhagat T, Nischal S, Christopeit M, Parekh S, Steidl U, Godley L, Maitra A, Greally J, Verma A NUCLEIC ACIDS RES. Cytogenetics of extramedullary manifestations in multiple myeloma Billecke L, Murga Penas E, May A, Engelhardt M, Nagler A, Leiba M, Schiby G, Kröger N, Zustin J, Marx A, Matschke J, Tiemann M, Goekkurt E, Heidtmann H, Vettorazzi E, Dierlamm J, Bokemeyer C, Schilling G BRIT J HAEMATOL.

Myogenic differentiation of mesenchymal stem cells in a newly developed neurotised AV-loop model Bitto F, Klumpp D, Lange C, Boos A, Arkudas A, Bleiziffer O, Horch R, Kneser U, Beier J BIOMED RES INT. Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic Syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data Brand R, Putter H, van Biezen A, Niederwieser D, Martino R, Mufti G, Onida F, Symeonidis A, Schmid C, Garderet L, Robin M, van Gelder M, Finke J, Bornhäuser M, Kobbe G, Germing U, de Witte T, Kröger N PLOS ONE.

The Gonads and their Magic Bullet, Lysophosphatidic Acid: Physiological and Toxicological Functions of Lysophosphatidic Acid LPA In Female and Male Reproductive Systems Budnik L, Brunswig-Spickenheier B, Müller D Lysophospholipid Receptors: Signaling and Biochemistry. Chun J, Hla T, Spiegel S, Moolenaar W Hrsg. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change Christopeit M, Kuss O, Finke J, Bacher U, Beelen D, Bornhäuser M, Schwerdtfeger R, Bethge W, Basara N, Gramatzki M, Tischer J, Kolb H, Uharek L, Meyer R, Bunjes D, Scheid C, Martin H, Niederwieser D, Kröger N, Bertz H, Schrezenmeier H, Schmid C J CLIN ONCOL.